Dmytruk Mark E.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Aug 6, 2024
- Accession no.
- 0001127602-24-021718
- Filed
- Aug 6, 2024, 4:37 PM ET
- Trade date
- Aug 1-2, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $18.2K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dmytruk Mark E.CIK 0001873507 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +65,449 | –F1 | – | 1,109,075 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +18,125 | –F1 | – | 1,127,200 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +22,917 | –F1 | – | 1,150,117 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,636 | –F3 | – | 1,151,753 | Direct | |
| Aug 2, 2024 | Class A Common Stock | SSaleDisposed | −63,567 | $0.287 | −$18,243.73 | 1,088,186 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −65,449 | –F1 | – | 450,639 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −18,125 | –F1 | – | 561,875 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −22,917 | –F1 | – | 985,417 | Direct | |
| Aug 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,636 | –F7 | – | 622,141 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Referenced by the price of 3 transactions in Table I and 3 transactions in Table II.
- F3
Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
Referenced by the price of 1 transaction in Table I.
- F7
Includes shares of Class B Common Stock that are subject to vesting conditions.
Referenced by the price of 1 transaction in Table II.
Remarks
Chief Financial Officer